
Pharmacally
Hematology
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Hematology
Mergers & AcquisitionsIncyte Bolsters Hematology Growth With $2 Billion Vega BuyoutIncyte has agreed to acquire Vega Therapeutics for up to $2 billion, gaining VGA039, a first-in-class anti-Protein S monoclonal antibody in Phase 3 development for von Willebrand disease.…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.